A054670 Stock Overview
Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Daehan New Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩7,880.00 |
| 52 Week High | ₩10,410.00 |
| 52 Week Low | ₩7,670.00 |
| Beta | 0 |
| 1 Month Change | -6.97% |
| 3 Month Change | -8.69% |
| 1 Year Change | -10.56% |
| 3 Year Change | -33.22% |
| 5 Year Change | -29.96% |
| Change since IPO | 3.68% |
Recent News & Updates
Recent updates
Daehan New Pharm Co., Ltd.'s (KOSDAQ:054670) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 10
What Type Of Shareholders Own The Most Number of Daehan New Pharm Co., Ltd. (KOSDAQ:054670) Shares?
Feb 17Here's Why Daehan New Pharm (KOSDAQ:054670) Can Manage Its Debt Responsibly
Jan 21
If You Had Bought Daehan New Pharm's (KOSDAQ:054670) Shares Five Years Ago You Would Be Down 25%
Dec 31Is Daehan New Pharm Co., Ltd.'s(KOSDAQ:054670) Recent Stock Performance Tethered To Its Strong Fundamentals?
Dec 10Shareholder Returns
| A054670 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | 3.9% | 0.5% |
| 1Y | -10.6% | 8.3% | 4.7% |
Return vs Industry: A054670 underperformed the KR Pharmaceuticals industry which returned 8.3% over the past year.
Return vs Market: A054670 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A054670 volatility | |
|---|---|
| A054670 Average Weekly Movement | 1.9% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A054670 has not had significant price volatility in the past 3 months.
Volatility Over Time: A054670's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | Geon-U Bae | www.dhnp.co.kr |
Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers human medicine products, such as circulatory and endocrine system drugs; animal medicines; biopharmaceuticals, including biomedicine serums; export medicine which comprises of antibiotics, antineoplastics, and others; health functional food, as well as vitamins; and beauty and medical devices. The company was formerly known as Daehan Shinyak Co., Ltd.
Daehan New Pharm Co., Ltd. Fundamentals Summary
| A054670 fundamental statistics | |
|---|---|
| Market cap | ₩110.60b |
| Earnings (TTM) | -₩4.00b |
| Revenue (TTM) | ₩54.48b |
0.0x
P/S Ratio0.0x
P/E RatioIs A054670 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A054670 income statement (TTM) | |
|---|---|
| Revenue | ₩54.48b |
| Cost of Revenue | ₩24.57b |
| Gross Profit | ₩29.91b |
| Other Expenses | ₩33.91b |
| Earnings | -₩4.00b |
Last Reported Earnings
Sep 30, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A054670 perform over the long term?
See historical performance and comparison